E
Edin Mujagic
Researcher at University Hospital of Basel
Publications - 34
Citations - 485
Edin Mujagic is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 9, co-authored 29 publications receiving 314 citations. Previous affiliations of Edin Mujagic include University of Basel.
Papers
More filters
Journal ArticleDOI
Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial
Walter P. Weber,Walter P. Weber,Edin Mujagic,Edin Mujagic,Marcel Zwahlen,Marcel Bundi,Henry Hoffmann,Henry Hoffmann,Savas D. Soysal,Savas D. Soysal,Marko Kraljević,Marko Kraljević,Tarik Delko,Tarik Delko,Marco von Strauss,Marco von Strauss,Lukas Daniel Iselin,Lukas Daniel Iselin,Richard X Sousa Da Silva,Jasmin Zeindler,Jasmin Zeindler,Rachel Rosenthal,Heidi Misteli,Heidi Misteli,Christoph H. Kindler,Peter Müller,Ramon Saccilotto,Ramon Saccilotto,Andrea Kopp Lugli,Andrea Kopp Lugli,Mark Kaufmann,Mark Kaufmann,Lorenz Gürke,Lorenz Gürke,Urs von Holzen,Daniel Oertli,Daniel Oertli,Evelin Bucheli-Laffer,Julia Landin,Julia Landin,Andreas F. Widmer,Andreas F. Widmer,Christoph A Fux,Walter R. Marti +43 more
TL;DR: The findings do not support any narrowing of the 60-min window for the administration of a cephalosporin with a short half-life, thereby obviating the need for increasingly challenging SAP timing recommendations.
Journal ArticleDOI
Therapeutic vascularization in regenerative medicine.
Roberto Gianni-Barrera,Nunzia Di Maggio,Ludovic Melly,Maximilian G. Burger,Edin Mujagic,Lorenz Gürke,Dirk J. Schaefer,Andrea Banfi +7 more
TL;DR: Recent insights into the mechanisms that regulate vessel stabilization and the switch between normal and aberrant vascular growth after VEGF delivery are presented, to identify novel molecular targets that may improve both safety and efficacy of therapeutic angiogenesis.
Journal ArticleDOI
Prevention and control of surgical site infections: review of the Basel Cohort Study.
Till Andrin Junker,Edin Mujagic,Henry Hoffmann,Rachel Rosenthal,Heidi Misteli,Marcel Zwahlen,Daniel Oertli,Sarah Tschudin-Sutter,Andreas F. Widmer,Walter R. Marti,Walter P. Weber +10 more
TL;DR: The Basel SSI Cohort Study suggested that SAP should be administered between 74 and 30 minutes before surgery, and the substantial economic burden of in-hospital SSI has been confirmed.
Journal ArticleDOI
Associations of Hospital Length of Stay with Surgical Site Infections
Edin Mujagic,Walter R. Marti,Michael Coslovsky,Savas D. Soysal,Robert Mechera,Marco von Strauss,Jasmin Zeindler,Franziska Saxer,Alexandra Mueller,Christoph A Fux,Christoph H. Kindler,Lorenz Gürke,Walter P. Weber +12 more
TL;DR: There was no significant independent association between preoperative length of stay and risk of SSI while SSI and postoperative LOS were significantly associated.
Journal ArticleDOI
Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial.
Edin Mujagic,Tibor Andrea Zwimpfer,Walter R. Marti,Marcel Zwahlen,Henry Hoffmann,Christoph H. Kindler,Christoph A Fux,Heidi Misteli,Lukas Daniel Iselin,Andrea Kopp Lugli,Christian A. Nebiker,Urs von Holzen,Fabrizio Vinzens,Marco von Strauss,Stefan Reck,Marko Kraljević,Andreas F. Widmer,Daniel Oertli,Rachel Rosenthal,Walter P. Weber +19 more
TL;DR: The design and protocol of a randomized controlled trial investigating the optimal timing of surgical antimicrobial prophylaxis will have an important impact on current international guidelines for infection control strategies in the hospital and are of significant interest for patient safety and healthcare economics.